Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 27, 2026 · Filed Mar 2, 2026
A Larimar Therapeutics director paid $25K out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month. Shares held went up 250% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$25,000
Shares × reported transaction price
$25K–$100K
+250.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
46 days after results of Jan 12, 2026, 20 days before results of Mar 19, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $5.31 on Feb 27, 2026, 211% above its 52-week low and 11% below its high, after a 56% rise over the previous 30 trading days
52-week range $1.71 (Apr 8, 2025) to $5.95 (Feb 25, 2026), 85% of the way up, from 251 adjusted closes. 30 trading days earlier: $3.41 on Jan 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
4 LRMR insiders bought within the same week. That happened once before in filings since 2014: Sep 2022. Frank E Thomas's first purchase of LRMR since Feb 2024
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.8% | −0.5% | +2.3% |
| 30 days | −13.1% | −3.6% | −9.5% |
| 90 days | −36.3% | +11.5% | −47.8% |
| 180 days | −30.7% | +12.8% | −43.4% |
Past results only. Not a forecast.
Insider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 4 days later
A Larimar Therapeutics director paid $10M out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month.
Insider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 4 days later
A Larimar Therapeutics director paid $5.42M out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month.
Insider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 4 days later
A Larimar Therapeutics director paid $4.16M out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.